How to prepare now for a recurrence of the 1918 influenza epidemic: Storing lymphocytes from 1918 survivors to use as antibody factories [6]

Medical Hypotheses

Volumn 65, Issue 3, 2005, Pages 627-628

  Altschuler, Eric Lewin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY PRODUCTION; CAUSE OF DEATH; HUMAN; INFLUENZA; INFLUENZA VIRUS; LETTER; LYMPHOCYTE; MEDICAL RESEARCH; PATIENT; PRIORITY JOURNAL; RECURRENT DISEASE; STORAGE; VIRUS STRAIN;

ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; CELL LINE, TRANSFORMED; DISEASE OUTBREAKS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; RECURRENCE; SURVIVORS;

HUMAN INFLUENZA VIRUS;

EID: 21844453692     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.04.001     Document Type: Letter

References (2)

1. D. Kobasa Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus Nature 431 2004 703 707
2. E. Traggiai, S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, and M.R. Gismondo An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Nat Med 10 2004 871 875